Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Predicting success of nerve blocks for pain relief in herpetic neuralgia

Official title: Predictors of Response to Ultrasound-Guided Thoracic Paravertebral Nerve Block in Patients With Herpetic Neuralgia

Run by Beni-Suef University · NCT06761924 · Data updated 2026-11-12

This study is testing what factors can help predict if nerve blocks will effectively relieve pain for adults with herpetic neuralgia.

More Patient Satisfaction trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment140 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Beni Suweif Governorate)
StatusRecruiting
StartedFebruary 2025
Main results expectedSeptember 2025
Study endsNovember 2025
Registry record updatedJanuary 7, 2025
Trial IDNCT06761924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 70 with a diagnosis of herpetic neuralgia and one dermatomal affection in the thoracic distribution.

Probably not a fit

Patients with contraindications to TPVB, severe comorbidities, or known allergies to the study medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the factors that predict the success of thoracic paravertebral nerve blocks (TPVB) in patients suffering from herpetic neuralgia. By examining demographic, clinical, and procedural variables, the research aims to enhance the effectiveness of TPVB and improve pain management strategies. The study focuses on adults aged 18 to 70 diagnosed with herpetic neuralgia, aiming to identify which patients are most likely to benefit from this intervention.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for patients suffering from herpetic neuralgia.

How similar studies have gone: Previous studies have shown that paravertebral nerve blocks can effectively treat acute pain in herpes zoster patients, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged from18 to 70 years
* Diagnosed with herpetic neuralgia.
* Able and willing to provide informed consent.
* ASA I - II
* One dermatomal affection
* Thoracic distribution

Exclusion Criteria:

* Contraindications to TPVB as ( Infection at site of injection, empyema , coagulopathy and neoplastic lesion occupying the paravertebral space)
* Known allergies to study medications (bupivacaine, Dexamethasone).
* Severe comorbidities that could interfere with study participation.

Where it's running

  • Beni Suef University Hospital
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.